Skip to main content
. Author manuscript; available in PMC: 2012 Oct 29.
Published in final edited form as: Urol Oncol. 2009 Dec 4;29(6):670–675. doi: 10.1016/j.urolonc.2009.10.003

Table 2.

Patient characteristics (n = 13)

No. of patients 13
Age, years
  Median 69
  Range 58–76
ECOG performance status
  0   6
  1   7
Baseline PSA (ng/ml)
  Median 57.1
  Range   9–832.5
Site of metastasis
  Bone 13
  Soft tissue   2
    Lung   0
    Liver   0
    Lymph nodes   2
  Pelvic mass   2
Prior hormonal manipulations 13
  1   2
  2   4
  ≥3   7
Prior palliative radiation treatment   3
Prior immunotherapy (vaccine)   3
Prior docetaxel-based chemotherapy   3